Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mehdi Bouhaddou

Showing results (1-10 of 73) with videos related to

Pageof 8
Sort By:
Molecular Biosystems|April 17, 2014
Dimerization-based control of cooperativityMehdi Bouhaddou, Marc R Birtwistle
ACS Chemical Neuroscience|September 27, 2017
Integrating Transcriptomic Data with Mechanistic Systems Pharmacology Models for Virtual Drug Combination TrialsAnne Marie Barrette, Mehdi Bouhaddou, Marc R Birtwistle
NAR Cancer|May 22, 2023
Current proteomics methods applicable to dissecting the DNA damage responseMonita Muralidharan, Nevan J Krogan, Mehdi Bouhaddou, et al.
Plos One|January 18, 2018
Analysis of copy number loss of the ErbB4 receptor tyrosine kinase in glioblastomaDeAnalisa C Jones, Adriana Scanteianu, Matthew DiStefano, et al.
Cell Reports|November 10, 2015
Engineered Mammalian RNAi Can Elicit Antiviral Protection that Negates the Requirement for the Interferon ResponseAsiel Arturo Benitez, Laura Adrienne Spanko, Mehdi Bouhaddou, et al.
Current Opinion in Genetics & Development|July 10, 2019
Mapping the protein-protein and genetic interactions of cancer to guide precision medicineMehdi Bouhaddou, Manon Eckhardt, Zun Zar Chi Naing, et al.
Nucleic Acids Research|June 18, 2025
HIV Vpr activates a nucleolar-specific ATR pathway to degrade the nucleolar stress sensor CCDC137Karly A Nisson, Rishi S Patel, Yennifer Delgado, et al.
NPJ Systems Biology and Applications|November 1, 2022
Network inference from perturbation time course dataDeepraj Sarmah, Gregory R Smith, Mehdi Bouhaddou, et al.
Cancer Discovery|May 24, 2020
The Landscape of Human Cancer Proteins Targeted by SARS-CoV-2Beril Tutuncuoglu, Merve Cakir, Jyoti Batra, et al.
Pharmacology & Therapeutics|February 21, 2022
Leveraging modeling and simulation to optimize the therapeutic window for epigenetic modifier drugsAntje-Christine Walz, Arthur J Van De Vyver, Li Yu, et al.
Pageof 8

Showing results (1-10 of 73) with videos related to

Sort By:
Pageof 8
Molecular Biosystems|April 17, 2014
Dimerization-based control of cooperativityMehdi Bouhaddou, Marc R Birtwistle
ACS Chemical Neuroscience|September 27, 2017
Integrating Transcriptomic Data with Mechanistic Systems Pharmacology Models for Virtual Drug Combination TrialsAnne Marie Barrette, Mehdi Bouhaddou, Marc R Birtwistle
NAR Cancer|May 22, 2023
Current proteomics methods applicable to dissecting the DNA damage responseMonita Muralidharan, Nevan J Krogan, Mehdi Bouhaddou, et al.
Plos One|January 18, 2018
Analysis of copy number loss of the ErbB4 receptor tyrosine kinase in glioblastomaDeAnalisa C Jones, Adriana Scanteianu, Matthew DiStefano, et al.
Cell Reports|November 10, 2015
Engineered Mammalian RNAi Can Elicit Antiviral Protection that Negates the Requirement for the Interferon ResponseAsiel Arturo Benitez, Laura Adrienne Spanko, Mehdi Bouhaddou, et al.
Current Opinion in Genetics & Development|July 10, 2019
Mapping the protein-protein and genetic interactions of cancer to guide precision medicineMehdi Bouhaddou, Manon Eckhardt, Zun Zar Chi Naing, et al.
Nucleic Acids Research|June 18, 2025
HIV Vpr activates a nucleolar-specific ATR pathway to degrade the nucleolar stress sensor CCDC137Karly A Nisson, Rishi S Patel, Yennifer Delgado, et al.
NPJ Systems Biology and Applications|November 1, 2022
Network inference from perturbation time course dataDeepraj Sarmah, Gregory R Smith, Mehdi Bouhaddou, et al.
Cancer Discovery|May 24, 2020
The Landscape of Human Cancer Proteins Targeted by SARS-CoV-2Beril Tutuncuoglu, Merve Cakir, Jyoti Batra, et al.
Pharmacology & Therapeutics|February 21, 2022
Leveraging modeling and simulation to optimize the therapeutic window for epigenetic modifier drugsAntje-Christine Walz, Arthur J Van De Vyver, Li Yu, et al.
Pageof 8